Yüklüyor......

Synergistic antiproliferative effects of arsenic trioxide (ATO) with bortezomib in mantle cell lymphoma (MCL)

Mantle cell lymphoma (MCL) is a subtype of B-cell Non-Hodgkin’s Lymphoma (NHL) and accounts for approximately 6% of all lymphomas. MCL is highly refractory to most chemotherapy including newer antibody-based therapeutic approaches, and high-grade MCL has one of the worst survival rates among NHLs. T...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Jung, Hyun Joo, Chen, Zheng, McCarty, Nami
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3894928/
https://ncbi.nlm.nih.gov/pubmed/22965904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23317
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!